Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)
9.71
-0.13 (-1.32%)
Apr 30, 2025, 3:00 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cardiovascular and Cerebrovascular Disease Medication | 384.55M |
Log In |
Log In |
Log In |
Log In |
Cardiovascular and Cerebrovascular Disease Medication Growth | -14.34% |
Log In |
Log In |
Log In |
Log In |
Musculoskeletal Systemic Drugs | 358.93M |
Log In |
Log In |
Log In |
Log In |
Musculoskeletal Systemic Drugs Growth | -2.34% |
Log In |
Log In |
Log In |
Log In |
Medication for Children | 188.17M |
Log In |
Log In |
Log In |
Log In |
Medication for Children Growth | 24.74% |
Log In |
Log In |
Log In |
Log In |
Respiratory System Medication | 179.61M |
Log In |
Log In |
Log In |
Log In |
Respiratory System Medication Growth | 27.96% |
Log In |
Log In |
Log In |
Log In |
Gynecological Diseases Medication | 92.37M |
Log In |
Log In |
Log In |
Log In |
Gynecological Diseases Medication Growth | -15.21% |
Log In |
Log In |
Log In |
Log In |
Anti-infective Drugs | 81.85M |
Log In |
Log In |
Log In |
Log In |
Anti-infective Drugs Growth | -14.98% |
Log In |
Log In |
Log In |
Log In |
Other Business | 59.09M |
Log In |
Log In |
Log In |
Log In |
Other Business Growth | 43.19% |
Log In |
Log In |
Log In |
Log In |
Other | 283.97M |
Log In |
Log In |
Log In |
Log In |
Other Growth | -35.14% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
China | 1.63B |
Log In |
Log In |
Log In |
Log In |
China Growth | -9.12% |
Log In |
Log In |
Log In |
Log In |